Merck & Co., Inc.
MRK
$150.53
per share, on-chain
What Merck & Co. does
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
- Industry
- Healthcare
- CEO
- Robert Davis
- Website
- merck.com
Ways to own Merck & Co., Inc.
There's one version of this stock on Firstshare.
OndoMRKonOur pick
Wider choice. Usually $20 minimum, and it can cost more when New York is closed.
Daily backing report (29 Oct) ↗Monthly backing report (Sep 2026) ↗
$150.53
Open, outside US hours
Price check
What a slice looks like
$10.00 buys you 0.066 of one Merck & Co. share.
That's 6.6% of one share. Small, but it's yours, and it moves with the real price. One share costs $150.53.